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Histamine: A Promoter of Xanthine Oxidase Activity in Intestinal 
Ischemia/Reperfusion 
By M.G. Caty, D.J. Schmeling, H.P. Friedl, K.T. Oldham, KS. Guice, and G.O. Till 
Ann Arbor, Michigan and Hamburg, West Germany 
l Xanthine oxidase (X0)-derived oxygen radicals are 
thought to play an important role in the intestinal injury 
resulting from ischemia and reperfusion. In vitro data 
shows enhanced X0 activity in the presence of histamine. 
Histamine is known to be released during intestinal ischemia 
and reperfusion. The purpose of this study was to evaluate 
the relationship between histamine and X0 in vivo in 
intestinal ischemia/reperfusion injury. Using an estab- 
lished model of gut ischemia and reperfusion, portal venous 
plasma was obtained and assayed for histamine levels, X0 
activity. and xanthine dehydrogenase (XD) activity follow- 
ing injury. Intestinal ischemia for 120 minutes resulted in a 
200% increase in plasma histamine levels (263.4 f 36.9 
nmol/mL control, v 546.7 + 35.1 nmol/mL experimental, 
P < .05j. Reperfusion for 15 minutes resulted in a further 
increase in plasma histamine (to 656.3 + 33.9 nmol/mL), 
compared with 120 minutes of ischemia alone. No signifi- 
cant change in plasma X0 activity resulted after simple 
ischemia for 120 minutes. However, X0 activity doubled 
within 15 minutes of reperfusion of the ischemic intestine 
(6.37 + 0.53 nmol D,- per milliliter per minute ~3.12 f 0.25 
nmol O,- per milliliter per minute, P < .05). Reperfusion for 
60 minutes resulted in the maximal observed increase in 
plasma X0 activity (9.49 + 0.67 nmol O,- per milliliter per 
minute). Analysis of XD activity demonstrated no signifi- 
cant decrease compared with controls until 120 minutes of 
ischemia and 60 minutes of reperfusion (1.62 f 0.49 nmol 
uric acid per milliliter per minute at 60 minutes of reperfu- 
sion, versus 5.02 2 0.52 nmol uric acid per milliliter per 
minute control, P < .05). These data suggest that en- 
hanced X0 activity due to calcium and protease-dependent 
conversion from XD results relatively late in the course of 
this ischemialreperfusion injury, after the histamine- 
associated early increase in plasma X0 activity. In sum- 
mary, intestinal ischemia followed by reperfusion results in 
parallel elevations of plasma histamine and X0 activity. 
The early increase in X0 activity is independent of conver- 
sion from XD but is temporally related to elevations in 
plasma histamine. These data suggest a role for histamine 
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I NTESTINAL ISCHEMIA followed by reperfusion is a frequent clinical event with important local and 
systemic consequences. Neonatal necrotizing enterocoli- 
tis, midgut volvulus, and nonocclusive mesenteric 
ischemia following resuscitation are all relevant clini- 
cal scenarios. The pathogenic mechanisms involved 
have been the focus of significant recent investigative 
efforts. This is related in part to the observations of 
Granger et al’ regarding the phlogistic role of oxygen- 
derived free radicals in this setting. Subsequently it has 
become apparent that oxidant-induced tissue injury is 
one aspect of a complex series of cellular and humoral 
events linked to the endogenous inflammatory re- 
sponse. These events in turn appear to play a role in the 
pathogenesis of multiorgan system failure.2 
Intestinal ischemic injury is thought to be initiated 
by interruption of intracellular, oxygen-dependent high- 
energy phosphate (adenosinetriphosphate [ATP]) pro- 
duction. The purine degradation products that result 
(Fig 1) include hypoxanthine. The net loss of cell 
charge is accompanied by increased cytosolic calcium, 
which is linked to the proteolytic conversion of xan- 
thine dehydrogenase (XD) to xanthine oxidase (XO).3 
Thus ischemia yields both a substrate (hypoxanthine) 
and an active enzyme (X0). When combined with 
molecular oxygen that is available as a result of 
reperfusion, the yield includes the superoxide anion 
(O,-), which in turn serves to generate a variety of 
additional short-lived, toxic oxygen radical species 
(H,O,, OH, HOCl, etc). 
This scenario is generally applicable to ischemia/ 
reperfusion events in many different target organs4y5; it 
was initially described in the cat intestine.6 Currently, 
there is abundant evidence and a consensus for a 
central role for X0 in the pathogenesis of intestinal 
ischemia/reperfusion injury.‘*6 
Despite this agreement on a role for X0, little is 
known about the control mechanisms that regulate its 
activity. Most investigators have focused on the events 
related to conversion of XD to X0 late in the course of 
this injury. The purpose of this study was to investigate 
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Fig 1. Purine degradation 
products resulting from isch- 
emia provide the substrate for 
xanthine oxidase and molecu- 
lar oxygen to generate oxygen- 
derived free radicals. This isch- 
emialreperfusion scenario was 
















a potential relationship between histamine and X0 in a 
model of intestinal ischemia/reperfusion injury. This 
was based on observations we have made in other in 
vivo experimental models’ and on work by Muroka in 
19638’9 demonstrating in vitro that X0 activity is 
enhanced by histamine. 
MATERIALS AND METHODS 
Animal Model 
Pathogen-free male Sprague-Dawley rats (Charles River Labora- 
tories, Portage, MI) weighing 100 to 150 g were used for all 
experiments. All experimental protocols were approved by the 
University of Michigan Committee on Use and Care of Animals and 
have been described previously. ” Following an overnight fast, 
animals were anesthetized by an intramuscular (IM) injection of 
ketamine hydrochloride (100 mg/kg). 
Midline laparotomy was performed, the superior mesenteric 
artery isolated, and total mesenteric occlusion achieved by place- 
ment of a microvascular clip. Sham animals underwent similar 
preparation but did not have clip placement. Reperfusion of the 
ischemic intestine was achieved by removal of the microvascular clip 
during a second laparotomy. During the period of ischemia and 
reperfusion, animals remained hemodynamically stable.” Once 
killed, portal venous blood samples were collected and diluted at a 1 
to 1 ratio with a processing and storage medium containing potas- 
sium phosphate (0.0024 mol/L), NaCl (0.15 mol/L) buffer, pH 
7.35, dithiothreitol (10 mmol/L); phenylmethyl sulfonyl fluoride (1 
mmol/L), and ethylenediaminotetraacetic acid (10 mmol/L). Fol- 
lowing centrifugation at 4OC, plasma samples were obtained for 
examination of histamine, X0 activity, and XD activity. 
XD/XO Activity 
X0 activity assessed by superoxide anion generation in rat plasma 
was assayed spectrophotometrically (Gilford Response II, Gilford 
software V5.01 with advanced enzyme kinetics; Ciba Corning 
Diagnostics Corp, Oberlin, OH) at 550 nm, continuously monitoring 
REPERFUSION 
the reduction of ferricytochrome c following addition of xanthine in 
the presence and absence of superoxide dismutase (SOD) at 37OC. 
The reaction mixture contained 300 pL ferricytochrome c (120 
pmol/L), 200 pL SOD (500 U) or buffer in the absence of SOD, 200 
NIL potassium phosphate (0.0024 mol/L) and sodium chloride (0.15 
mol/L) at pH 7.35, and 200 pL rat plasma. The reaction mixture 
was preincubated at 37OC for 3 minutes and subsequently started by 
addition of 100 rL xanthine (50 rmol/L). The contents of the 
reference cuvette were the same except that plasma and xanthine 
were omitted. The amount of superoxide formed was calculated from 
the difference in optical density (01)) readings (*SOD) after 10 
minutes of reaction time using a molar extinction coefficient of 2 1.1 
cm-l mmol/L-1 for cytochrome c.” X0 activity wasexpressed as 
nmol O,- formed per milliliter of plasma per minute. As expected, 
addition of allopurinol (1 mmol/L) or SOD (500 U) or omission of 
xanthine completely prevented the reduction of cytochrome c (data 
not presented). 
Uric acid formation. XD and X0 .activities were assayed by 
measurement of uric acid formation at 293 nm in the presence or 
absence of NAD’ at 37”C, as described by Waud and Rajagopalan.‘* 
The reaction mixture contained 100 PL xanthine (50 rmol/L), 100 
rL NAD+ (500 rmol/L) or buffer (in the absence of NAD’), 600 
pL potassium phosphate (0.0024 mol/L) and sodium chloride (0.15 
mol/L) at pH 7.35, and 100 r.rL rat plasma to a final plasma content 
of 5% (vol/vol). Furthermore, as indicated, the reaction mixture 
contained 100 pL of the uricase inhibitor 2,4 dihydroxy-6-carboxy- 
1.35 triazine (oxonate)” (Aldrich Chemical Co Inc, Milwaukee, 
WI) present in a final concentration of 3 pmol/L. X0 and XD 
activities were_ expressed as nanomoles of uric acid formed per 
milliliter of plasma per minute. 
Histamine-Radioimmunoassay 
To determine plasma histamine, a commercially available immu- 
noassay kit from Amac Inc (Westbrook, ME) was used. This assay is 
based on the acylation of plasma histamine and its competition with 
I’*‘-acylated histamine for binding to a mouse monoclonal antibody. 
Results were calculated employing a standard curve from seven 
standard samples ranging between 0 and 150 nmol/mL. Results 
were expressed as nmol/mL. 
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Statistics 
Data are expressed as mean + standard error of the mean. 
Significance between controls and experimental groups was deter- 
mined using a two-way analysis of variance in combination with the 
Dunn&t’s multiple comparison test, with significance defined at 
P < .os. 
RESULTS 
Histamine Levels After Intestinal Ischemial 
Reperfusion 
Intestinal ischemiaalowed by reperfusion resulted 
in significant release of histamine into portal vein 
plasma (Fig 2). Sham-operated animals had plasma 
histamine levels of 263.4 f 36.9 nmol/mL. Intestinal 
ischemia of 120 minutes’ duration resulted in a dou- 
bling in plasma portal venous histamine levels (263.4 + 
36.9 nmol/mL v 548.7 f 35.1 nmol/mL, P -C .05). A 
further increase in plasma histamine levels occurred 
with 120 minutes of ischemia followed by 15 minutes 
of reperfusion (658.3 + 33.9 nmol/mL). 
X0 Activity Levels After Intestinal 
IschemialReperfusion 
X0 activity was measured in the same plasma 
samples obtained for histamine levels (Fig 3). No 
significant increase in X0 activity occurred after 120 
minutes of ischemia alone (3.71 + 0.26 nmol O,- per 
milliliter per minute v 3.12 + 0.23 nmol O,- per 
milliliter per minute for control animals, P > .05). 
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Fig 2. Portal vanous plasma histamine levels during ischemia 
and reperfusion of the intestine. Time points on the x axis 
represent minutes of ischemia per minutes of reperfusion; eg, 
120/15 represents 120 minutes of ischemia and 15 minutes of 
reperfusion. P c.06 (0) compared with sham-operated control 
animals using an analysis of variance in combination with Dun- 
natt’s multiple comparison test. 
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Fig 3. Plasma X0 activity during ischemia and reperfusion. P < 
.06 compared with O/O sham (e) and 120/O groups (#) using an 
analysis of variance in combination with Dunnett’s multiple compar- 
ison test. X0 activity was unchanged with ischemia alone. but was 
significantly enhanced within 15 minutes of reperfusion. 
resulted in a doubling of X0 activity compared with 
control animals (6.37 f 0.53 nmol O,- per milliliter 
per minute v 3.12 + 0.23 nmol O,- per milliliter per 
minute, P < .05) and a 140% increase over animals 
subjected to 120 minutes of ischemia alone (6.37 + 0.53 
nmol O,- per milliliter per minute v 3.71 k 0.26 nmol 
O,- per milliliter per minute, P < .05). Reperfusion of 
the ischemic intestine for 60 minutes produced the 
highest levels of X0 activity observed (9.49 + 0.67 
nmol O,- per milliliter per minute). 
XD Activity During intestinal IschemialReperfusion 
The proposed pathogenesis of intestinal ischemia/ 
reperfusion injury has assumed the conversion of XD 
to X0 (Fig 1). In order to characterize the relationship 
between X0 and histamine, XD activity was assessed 
at the same time points (Fig 4). Despite a trend toward 
decreasing plasma XD activity after 120 minutes of 
ischemia and 15 minutes of reperfusion, no significant 
decrease in activity occurred until 120 minutes of 
ischemia and 60 minutes of reperfusion (1.62 f 0.49 
nmol uric acid per milliliter per minute v 5.02 t 0.57 
nmol uric acid per milliliter per minute, P -C .05). 
DISCUSSION 
Histamine is an abundant constituent of intestinal 
mast cells.14 Many stimuli are known to liberate 
histamine from mast cells. Among these stimuli are 
complement peptides, IgE, mechanical or thermal 
trauma, and oxygen radicals.i5-” Masini et a1,18 using 
an isolated guinea pig heart, demonstrated a signifi- 
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Fig 4. Plasma XD activity during intestinal ischemia and 
reperfusion. P c.05 (0) compared with sham animals using en 
analysis of variance in combination with Dunnett’s test. Significant 
XD conversion (to X0) did not occur until after 60 minutes of 
reperfusion. At 15 minutes of reperfusion, no significant XD to X0 
conversion had occurred despite the increase in X0 shown in Fig 3. 
cant release of histamine during myocardial reperfu- 
sion, which they attributed to oxygen radical-mediated 
exocytosis from mast cells. 
A pathogenic role for histamine in intestinal isch- 
emia and reperfusion has been suggested by Kusche et 
a1.19*20 They demonstrated significant increases in mor- 
tality in animals given aminoguanethidine, a potent 
inhibitor of diamine oxidase (histaminase) during in- 
testinal ischemia and reperfusion. Although the impor- 
tance of histamine as a vasoactive substance was the 
emphasis of this study, the observation by Kusche et al 
has implications for our study of histamine-enhanced 
X0 activity. 
In this model, intestinal ischemia and reperfusion 
resulted in parallel elevations of plasma histamine and 
X0 activity, the rise in histamine preceding X0 
temporally. An increase in X0 activity at 120 minutes 
of ischemia and 15 minutes of reperfusion was indepen- 
dent of conversion from XD as there was no significant 
reduction in XD activity (Fig 4). By 120 minutes of 
ischemia and 60 minutes of reperfusion there was a 
significant conversion of XD to X0. A comparison of 
the total activity of X0 plus XD is provided in Fig 5. A 
significant increase in the total (X0 plus XD) activity 
occurred at 120 minutes of ischemia and 15 minutes of 
reperfusion, but XD activity was unchanged. Accord- 
ingly, the increase in combined (X0 plus XD) total 
activity must result from an increase in X0 activity 
independent of XD to X0 conversion. As XD to X0 
conversion occurs by 60 minutes of reperfusion, the 
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increase in X0 activity at this time seems to result 
from conversion from XD. The earlier conversion- 
independent increase in plasma X0 activity (at 120/ 
15) that is associated with histamine elevations, paral- 
lels in vitro findings of histamine enhancement of X0 
activity.’ 
The mechanism of histamine’s effect on X0 is 
unknown. Work by Till et al” with a thermal injury 
model characterized by histamine release and in- 
creased X0 activity has demonstrated no protective 
effect of H, antagonists and only partial protection 
with H2 antagonists. Complete protection was afforded 
by cromolyn sodium, a mast cell stabilizer,7 and a 
potent inhibitor of histamine release. This would impli- 
cate a histamine receptor-independent effect of hista- 
mine on X0 and suggests an allosteric enhancement of 
the enzyme by histamine. This concept remains specu- 
lative and awaits experimental confirmation. 
We have demonstrated a temporal relationship be- 
tween plasma histamine elevation and a (XD) conver- 
sion-independent increase in X0 activity at early time 
points of intestinal ischemia and reperfusion. Later 
increases in X0 activity resulted from the conversion 
from XD in this model and as others have suggested. 
This raises the possibility of a bimodal control of X0 
activity in intestinal ischemia/reperfusion and infers a 
pathogenic role for histamine in the injury. Pharmaco- 
logic therapy directed against histamine may have 
important effects on the injury resulting from intesti- 
nal ischemia and reperfusion. 
* 
010 12010 120/15 120/60 
TIME (min) 
Fig 5. Total plasma X0 and XD activity during intestinal 
ischemia and reperfusion. P ~05 (0) compared with sham animals 
using an analysis of variance in combination with Dunnett’s test. 
Significant XD to X0 conversion did not take place until Bo minutes 
of reperfusion had occurred. although a significant increase in X0 
activity occurred within 15 minutes of reperfusion. 
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Discussion 
M. Clemens (Baltimore, MD): Your presentation 
has introduced us to a slightly different way of thinking 
about the free radical story, especially in intestinal 
ischemia. I have just a couple of questions, primarily 
with respect to compartmentalization. The X0 and 
XD levels that you are reporting are plasma values, 
whereas we would think that the ones that wauld be 
most important for generating free radicals to cause 
tissue injury would be tissue X0. Have you measured 
any tissue values of the increase in the X0 activity, and 
also when you reported that by blocking the histamine 
production you decrease the amount of plasma X0 
activity, did this result in an improvement in tissue 
function or an amelioration of tissue injury during 
reperfusion? 
W. Andrews (Dallas. TX): In our hands we have 
been looking at mesenteric occlusion in rats and 
looking at survivability. We found that at 60 minutes 
of occlusion there is about 80% mortality, and with 90 
minutes of occlusion 100% mortality results with 
severe bowel necrosis. You have used 120 minutes of 
intestinal ischemia. Have you done any of these studies 
in some lower time periods of occlusion? Is there a 
dose- or time-response curve to histamine release, or is 
this seen only at a very severe level of ischemia? 
P. Cherko (Philadelphia, PA): Have your correlated 
your increased levels of X0 activity due to histamine 
enhancement with histologic sections? 
M.G. Caty (response): Dr Clemens, in other experi- 
mental models we have demonstrated that a rise in 
plasma X0 activity correlates with a rise in tissue X0 
activity. In this experiment, we measured plasma X0 
and XD to allow a more direct comparison with plasma 
histamine activity. When we used cromolyn sodium in 
animals subjected to intestinal ischemia and reperfu- 
sion, there was a decrease in plasma histamine and a 
concomitant decrease in plasma X0 activity. In addi- 
tion, there was protection against oxidant-mediated 
tissue injury as.measured by lipid peroxidation prod- 
ucts. At the early time points, 120 minutes of ischemia 
and 15 minutes of reperfusion, there was a reduction in 
lipid peroxidation products as well as preservation of 
tissue adenosine triphosphate when cromolyn sodium 
was used. At the later time points, the protection was 
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not apparent but that would be expected since there 
was XD-to-X0 conversion by that time, and presum- 
ably the histamine effect would no longer be important. 
Dr Andrews, in a series of in vitro experiments we 
have demonstrated that histamine’s effect on X0 
activity is concentration-dependent. In earlier in vivo 
experiments, we looked at 60 minutes of intestinal 
ischemia, and found that histamine levels in the portal 
venous blood did not reach the in vitro threshold level 
necessary to induce an increase in X0 activity. With 
respect to survivability, we found that animals sub- 
jected to 60 minutes of intestinal ischemia had a 
mortality rate of approximately 50% to 60% at 24 
hours. These data are from a much earlier time point. 
In our model, 120 minutes of ischemia yields a predict- 
ably lethal injury. 
Dr Cherko, we have found, as I showed on the 
electronmicrographs, that when we gave cromolyn 
sodium to animals subjected to intestinal ischemia, 
mast cell degranulation was prevented and normal 
cellular architecture was better preserved. We have 
not done this analysis in a quantitative way. 
